Hanall Biopharma

한올바이오파마KRX: 009420· Fiscal year 2025· hanall.co.kr ↗

Average salary
$61.7K
₩82.1M
▲ 4.3% vs 2024
Employees
315
▼ 0.9% vs 2024
Average tenure
Not disclosed

Estimated take-home of this pay:$4.1K / monthCalculate →

Workplace

Women's pay (men = 100)81
Women among staff33%
Contract staff4.4%

Recent official filings

Quick read

  • Average pay is 34% above the median of the companies we track.
  • Average pay rose 4.3% from 2024.
  • Headcount shrank by 3 (0.9%) from 2024.
  • Ranks #19 of 238 Healthcare & Pharma companies in this country by pay.
  • Revenue grew 11.7% year over year.
  • Revenue has grown two years in a row.
  • Operating loss of $685.8K in 2025.

Last 3 years

Revenue
$101.3M2023$104.3M2024$116.5M2025
Operating income
$1.7M2023$173.0K2024-$687.4K2025

See the share price on Naver Finance ↗

Investor metrics

2025
Revenue per employee
$368.9K
Net profit per employee
-$13.2K
Operating margin
-0.6%
Net margin
-3.6%
ROE
-3.4%
Debt-to-equity
39.3%
Equity ratio
71.8%

Per-employee figures use the company headcount, so they run high for groups with many subsidiaries. Not investment advice.

Similar companies

USD at ₩1,332.22 per $1 (2026-11-19, ExchangeRate-API)

Source: DART (Financial Supervisory Service, Korea)

Not investment advice. Figures come from public filings and may contain errors.